Evidence map›Paper›PMID 41665774›Full record

ReviewStem cell reviews and reports2026

Stem Cell-based Nerve Regenerative Therapies: The Role of Adipose-Derived Stem Cells (ADSCs) in Preventing Nerve Adhesions and Promoting Axonal Nerve Repair.

Anam Anjum, Ubashini Vijakumaran, Hafiz Bilawal Hussain, Samrah Khalid, Mousumi Ghosh

Abstract readReview
PubMed Publisher
In one paragraph

Review in Stem cell reviews and reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Anam AnjumDepartment of Neurosurgery, University of Maryland School of Medicine, Baltimore, MD, 21201, USA. aanjum@som.umaryland.edu.ORCID http://orcid.org/0000-0003-4675-9728
Ubashini VijakumaranInstitute of Medical Science Technology, Universiti Kuala Lumpur, Kajang, 43000, Malaysia.
Hafiz Bilawal HussainDepartment of Orthopaedic Surgery and Traumatology Unit-1, Jinnah Hospital Lahore, Jinnah Hospital, Allama Iqbal Medical College, Lahore, 54550, Pakistan.
Samrah KhalidDepartment of Internal Medicine, Medical Unit 4, Jinnah hospital Lahore, Allama Iqbal Medical College, Lahore, 54550, Pakistan.
Mousumi GhoshThe Miami Project to Cure Paralysis, University of Miami Miller School of Medicine, Miami, FL, 33136, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Damage to either the central or peripheral nervous system can result in significant impairments of movement and sensation, with poor regeneration often resulting from complications such as nerve adhesion and fibrosis. Adipose-derived stem cells (ADSCs) have emerged as a promising therapeutic candidate in promoting nerve regeneration owing to their regenerative potential, abundance, ease of harvest, low immunogenicity, and anti-inflammatory properties. ADSCs, isolated from adipose tissue, can differentiate into neural lineages, secrete a broad spectrum of neurotrophic and anti-fibrotic factors, and thereby foster axonal sprouting, remyelination, and scar attenuation. Additionally, these cells have demonstrated efficacy in preventing nerve adhesion, a common complication of nerve injury that impedes functional recovery. This review explores the properties, advantages, and regenerative potential of ADSCs, highlighting their roles in promoting axonal regeneration, myelination, and reducing fibrosis. Preclinical studies and early clinical trials associated with the peripheral and central nervous system injuries have reported promising results in terms of functional recovery and reduced scar formation, but challenges remain in standardizing ADSC-based therapies and achieving full functional restoration. Future advancements in ADSC therapies may include optimized delivery systems, genetic modifications, and the integration of advanced biomaterials to enhance their regenerative capabilities.

Indexed as

Adipose TissueAxonsNerve RegenerationPeripheral Nerve InjuriesStem CellsStem Cell TransplantationAnimalsHumansTissue AdhesionsAdipose-derived stem cells (ADSCs)And schwann cells (SCs)Axonal regenerationCell transplantationFibrotic scarringNerve adhesionPeripheral nerve injury (PNI)

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.